Proteomics and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging as a Modern Diagnostic Tool in Kidney Diseases
Journal Title: Нирки - Year 2017, Vol 6, Issue 1
Abstract
As a result of the rapid evolution of modern science, we are continually improving our knowledge of disease pathogenesis and morphology on a daily basis. Due to the era of omics sciences, such as genomics, transcriptomics, and proteomics, there is a strong desire to comprehend the molecular mechanisms of diseases and organisms. The final aims would be to perform more successful diagnosis/prognosis, identify potential therapeutic targets, and predict treatment response. Chronic kidney disease (CKD) is a worldwide health problem with a rapidly increasing incidence, with CKD itself encompassing a large subset of diseases. Recently, modern proteomic technologies, such as matrix-assisted laser desorption/ionization mass spectrometry imaging, have been employed in order to study CKD. Notwithstanding the general infancy of these methodologies, there are already an impressive number of studies and publications related to this subject.
Authors and Affiliations
Mariia Ivanova, Olena Dyadyk, Andrew Smith, Lucia Santorelli, Martina Stella, Manuel Galli, Clizia Chinello, Fulvio Magni
Keywords
Related Articles
- EP ID EP208746
- DOI 10.22141/2307-1257.6.1.2017.93780
- Views 87
- Downloads 0
Pharmacogenetic Tests in the Nephrological Clinic
Selection of antihypertensive agents using pharmacogenetic tests and individual tolerance is essential in practical nephrology. Antihypertensive first-line drugs are metabolized through various CYP isoforms (CYP2D6, CYP2...
Uric Acid and its Role in the Progression of Chronic Kidney Disease: Do We Know Enough?
At the present stage of medical science development, the role of hyperuricemia as the factor of chronic kidney disease progression is actively discussed. Some epidemiological studies have been presented to evaluate the r...
Renoprotection and its association with eGFR and renal functional reserve
Renoprotection is a system of measures for primarily pharmacological control, contributing to the continued preservation of renal function. When choosing renoprotection tactics, it is necessary to consider not only the e...
The current strategy was the use of neuroprotective protein diet purposes.
This article provides an overview of the scientific evidences on the use of low-protein diet by patients with chronic kidney disease. Their analysis show that low-protein diet refers to the recommendations of a high lave...
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney dis...